Uveal Effusion Syndrome

Survey of Ophthalmology

Volumn 55, Issue 2, 2010, Pages 134-145

  Elagouz, Mohammed ^a,b   Stanescu Segall, Dinu ^a   Jackson, Timothy L ^a,c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b Sohag University   (Egypt)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

hypermetropia; idiopathic; nanophthalmia; sclera; sclerectomy; sclerostomy; uveal effusion syndrome

Indexed keywords

COLLAGEN FIBER; GLYCOSAMINOGLYCAN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN DERIVATIVE; STEROID;

CENTRAL SEROUS RETINOPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG MEGADOSE; FLUID RETENTION; HISTOPATHOLOGY; HUMAN; HYPERMETROPIA; INTRAOCULAR HYPOTENSION; LASER COAGULATION; MICROPHTHALMIA; NONHUMAN; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DETACHMENT; REVIEW; SCLERA DISEASE; SCLERECTOMY; SCLEROTOMY; SUBRETINAL FLUID; SURGICAL ANATOMY; UVEA DISEASE; UVEA EFFUSION SYNDROME; VISUAL ACUITY;

BODY FLUIDS; CAPILLARY PERMEABILITY; CHOROID DISEASES; DECOMPRESSION, SURGICAL; EXUDATES AND TRANSUDATES; HUMANS; SCLERA; SCLEROSTOMY; SYNDROME;

EID: 75949128697     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2009.05.003     Document Type: Review

References (53)

1. Akduman L., Adelberg D.A., and Del Priore L.V. Nanophthalmic uveal effusion managed with scleral windows and topical mitomycin-C. Ophthalmic Surg Lasers 28 (1997) 325-327
2. Allen K.M., Meyers S.M., and Zegarra H. Nanophthalmic uveal effusion. Retina 8 (1988) 145-147
3. th ed. (1992), Mosby, London chap. 6
4. Anderson O.A., Jackson T.L., Singh J.K., et al. Human transscleral albumin permeability and the effect of topographical location and donor age. Invest Ophthalmol Vis Sci 49 9 (2008) 4041-4045
5. Benson W.E., Shields J.A., Annesley W.H., et al. Idiopathic central serous choroidopathy with bullous retinal detachment. Ann Ophthalmol 12 (1980) 920
6. Bill A. Movement of albumin and dextran through the sclera. Arch Ophthalmol 74 (1965) 248-252
7. Bill A., and Wahlinder P.E. The effects of pilocarpine on the dynamics of aqueous humor in a primate (Macaca irus). Invest Ophthalmol 5 (1966) 170-175
8. Boubriak O.A., Urban J.P., and Bron A.J. Differential effects of aging on transport properties of anterior and posterior human sclera. Exp Eye Res 76 (2003) 701-703
9. Boubriak O.A., Urban J.P., Akhtar S., et al. The effect of hydration and matrix composition on solute diffusion in rabbit sclera. Exp Eye Res 71 (2000) 503-514
10. Brockhurst R.J. Vortex vein decompression for nanophthalmic uveal effusion. Arch Ophthalmol 98 (1980) 1987-1990
11. Brockhurst R.J. Discussion of Gass JDM. Uveal effusion syndrome. A new hypothesis concerning pathogenesis and technique of surgical treatment. Trans Am Ophthalmol Soc 81 (1983) 256
12. Brockhurst R.J. Nanophthalmos with uveal effusion: a new clinical entity. Arch Ophthalmol 93 (1975) 1289-1299
13. Brockhurst R.J. Uveal effusion. In: Albert D.M., and Jakobiec F.A. (Eds). Principles and Practice of Ophthalmology: Clinical Practice (1994), Saunders, Philadelphia, PA 548-559
14. Brockhurst R.J., and Lam K.W. Uveal effusion. II. Report of a case with analysis of subretinal fluid. Arch Ophthalmol 90 (1973) 399
15. Calhoun Jr. F.P. The management of glaucoma in nanophthalmos. Trans Am Ophthalmol Soc 73 (1975) 97-122
16. Casswell A.G., Gregor Z.J., and Bird A.C. The surgical management of uveal effusion syndrome. Eye 1 (1987) 115-119
17. Cintron C., Fujikawa L.S., Covington H., et al. Fibronectin in developing rabbit cornea. Curr Eye Res 4 (1984) 489
18. Daniele S., and Schepens C.L. Can chronic bulbar hypotony be responsible for uveal effusion? Report of two cases. Ophthalmic Surg 20 (1989) 872
19. Davies E.W.G., Sanders M.D., and Harry J. Annular serous detachment of the choroid. Trans Ophthalmol Soc UK 93 (1973) 145
20. Duke-Elder S. Normal and abnormal development. Congenital deformities. In: Duke-Elder S. (Ed). System of Opthalmology, vol. 3 (1964), CV Mosby, St Louis, MO 488
21. Emi K., Pederson J.E., and Toris C.B. Hydrostatic pressure of the suprachoroidal space. Invest Ophthalmol Vis Sci 30 (1989) 233-238
22. Forrester J.V., Lee W.R., Kerr P.R., and Dua H.S. The uveal effusion syndrome and trans-scleral flow. Eye 4 (1990) 354-365
23. Gass J.D.M. Bullous retinal detachment: an unusual manifestation of idiopathic central serous choroidopathy. Am J Ophthalmol 75 (1973) 810
24. Gass J.D.M. Uveal effusion syndrome: a new hypothesis concerning pathogenesis and technique of surgical treatment. Retina 3 (1983) 159-163
25. Gass J.D.M., and Jallow S. Idiopathic serous detachment of the choroid, ciliary body, and retina (uveal effusion syndrome). Ophthalmology 89 (1982) 1018-1032
26. Jackson T.L., Hussain A., Hodgetts A., et al. Human scleral hydraulic conductivity: age-related changes, topographical variation, and potential scleral outflow facility. Invest Ophthalmol Vis Sci 47 (2006) 4942-4946
27. Jackson T.L., Hussain A., Morley A.M.S., et al. Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome. Invest Ophthalmol Vis Sci 49 (2008) 5033-5040
28. Johnson M.W., and Gass J.D.M. Surgical management of the idiopathic uveal effusion syndrome. Ophthalmology 97 (1990) 778-785
29. Kelly D.E., Hageman G.S., and McGregar J.A. Uveal compartmentalization in the hamster eye revealed by fine structural and tracer studies: implications for uveoscleral outflow. Invest Ophthalmol Vis Sci 24 (1983) 1288-1304
30. Kerstetter J.R., Brubaker R.F., and Wilson S.E. Prostaglandin F2 alpha 1-isopropylester effects on aqueous humor dynamics in human subjects. Invest Ophthalmol Vis Sci 28 Suppl (1987) 266
31. Kimbrough R.L., Trempe C.L., Brockhurst R.J., et al. Angle-closure glaucoma in nanophthalmos. Am J Ophthalmol 88 (1979) 572
32. Kumar A., Kedar S., and Singh R.P. The indocyanine green findings in idiopathic uveal effusion syndrome. Indian J Ophthalmol 50 (2002) 217-219
33. Kumar R.S., Quek D., Lee K.Y., et al. Confirmation of the presence of uveal effusion in Asian eyes with primary angle closure glaucoma: an ultrasound biomicroscopy study. Arch Ophthalmol 126 12 (2008) 1647-1651
34. Lam A., Sambursky R.P., and Maguire J.I. Measurement of scleral thickness in uveal effusion syndrome. Am J Ophthalmol 140 2 (2005) 329-331
35. Levick J.R. Flow through interstitium and other fibrous matrices. Q J Exp Physiol 72 (1987) 409-437
36. Okabe H., Kiyosawa M., Katsuyoshi M., et al. Nuclear magnetic resonance imaging of subretinal fluid. Am J Ophthalmol 102 (1986) 640
37. Olsen T.W., Aaberg S.Y., Geroski D.H., and Edelhauser H.F. Human sclera: thickness and surface area. Am J Ophthalmol 125 (1998) 237-241
38. Pederson J.E., Gaasterland D.E., and MacLellan H.M. Uveoscleral aqueous outflow in the rhesus monkey: importance of uveal reabsorption. Invest Ophthalmol Vis Sci 16 (1977) 1008
39. Pederson J.E., Gaasterland D.E., and MacLellan H.M. Experimental ciliochoroidal detachment: effect on intraocular pressure and aqueous flow. Arch Ophthalmol 97 (1979) 546
40. Ryan E.A., Zwaan J., and Chylack Jr. L.T. Nanophthalmos with uveal effusion. Clinical and embryologic considerations. Ophthalmology 89 (1982) 1013-1017
41. Sakai H., Morine-Shinjyo S., Shinzato M., et al. Uveal effusion in primary angle-closure glaucoma. Ophthalmology 112 3 (2005) 413-419
42. Sakai H., Sakima N., Nakamura Y., et al. Ciliochoroidal effusion induced by topical latanoprost in a patient with Sturge-Weber syndrome. Jpn J Ophthalmol 46 (2002) 553-555
43. Schepens C.L., and Brockhurst R.J. Uveal effusion. I. Clinical picture. Arch Ophthalmol 70 (1963) 189-201
44. Shaffer R.N. Discussion of: Calhoun FP Jr. The management of glaucoma in nanophthalmos. Trans Am Ophthalmol Soc 73 (1975) 96-122 119-20
45. Stewart J.M., Schultz D.S., Lee O.T., and Trinidad M.L. Exogenous collagen cross-linking reduces scleral permeability: modeling the effects of age-related cross-link accumulation. Invest Ophthalmol Vis Sci 50 1 (2009) 352-357
46. Suzuki Y., Nishina S., and Azuma N. Scleral window surgery and topical mitomycin C for nanophthalmic uveal effusion complicated by renal failure. Graefe's Arch Clin Exp Ophthalmol 245 (2007) 755-757
47. Toris C.B., and Pederson J.E. Aqueous humor dynamics in experimental iridocyclitis. Invest Ophthalmol Vis Sci 28 (1987) 477
48. Trelstad R.L., Silbermann N.N., and Brockhurst R.J. Nanophthalmic sclera: ultrastructural, histochemical, and biochemical observations. Arch Ophthalmol 100 (1982) 1935-1938
49. Uyama M., Takahashi K., Kozaki J., et al. Uveal effusion syndrome-clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology. Ophthalmology 107 (2000) 441-449
50. Ward R.C., Gragoudas E.S., Pon D.M., and Albert D.M. Abnormal scleral findings in uveal effusion syndrome. Am J Ophthalmol 106 (1988) 139-146
51. Wilson R.S., Hanna C., and Morris M.D. Idiopathic chorioretinal effusion: an analysis of extracellular fluids. Ann Ophthalmol 9 (1977) 647
52. Yue B.Y.J.T., Duvall J., Goldberg M.F., et al. Nanophthalmic sclera: morphologic and tissue culture studies. Ophthalmology 93 (1986) 534
53. Yue B.Y.J.T., Kurosawa A., Duvall J., et al. Nanophthalmic sclera. Fibronectin studies. Ophthalmology 95 (1988) 56-60